Which nutrition therapy is currently favored in early post transplant hematopoietic cell transplant patients?

• A. Enteral nutrition is clearly superior to parenteral nutrition.
• B. Parenteral nutrition is preferred due to modest evidence.
• C. There is insufficient data to establish benefits of enteral nutrition; parenteral nutrition may increase survival in allogeneic patients.
• D. No nutrition support is indicated.

Answer: (C)

In this setting, the key principle is that evidence guiding nutrition support after hematopoietic cell transplantation is not definitive. Early post-transplant patients are highly catabolic and often have mucosal injury, GI intolerance, and immune considerations that complicate nutrition delivery. While keeping the gut fed (enteral nutrition) has theoretical and general ICU benefits, the available data in hematopoietic cell transplant recipients do not consistently show a clear advantage of enteral nutrition over other approaches. Consequently, there isn’t enough evidence to establish a definite benefit for enteral feeding in this specific group.

Parenteral nutrition becomes a practical option when the gut cannot be used safely or effectively, ensuring adequate energy and protein delivery during a period of extreme metabolic stress. In allogeneic transplant patients, some studies have suggested that parenteral nutrition may be associated with improved survival, though the data are not conclusive and vary by study design and patient factors. The takeaway is to tailor nutrition support to the individual’s tolerance and clinical status: use enteral nutrition when feasible and well-tolerated, but rely on parenteral nutrition when enteral feeding is not feasible or does not meet needs, since it may influence outcomes in allogeneic recipients.